References
Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani T, Zografos G, Gogas H et al Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Co-operative Oncology Group Trial. Breast Cancer Res Treat
Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML et al (2008) Estrogen-and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. J Clin Oncol 20(26):2473–2481. doi:10.1200/JCO.2007.13.6424
Bianchini G, Zambetti M, Pustzai L, Carcangiu ML, Valagussa P, Gianni L (2007) Use of estrogen receptor (ER) expression by quantitative RT-PCR to identify an ER-negative subgroup by IHC who might benefit from hormonal therapy. 2007 Breast Cancer Symposium; Abstr 106
Gong Y, Yan K, Lin F, Anderson K, Sotiriou C, Andre F et al (2007) Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol 8:203–211. doi:10.1016/S1470-2045(07)70042-6
Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC et al (2004) Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 164:35–42
Abramovitz M, Ordanic-Kodani M, Wang Y, Li Z, Catzavelos C, Bouzyk M et al (2008) Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques 44:417–423. doi:10.2144/000112703
Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. Biotechniques 29:332–337
Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L (2005) Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 4:1149–1152
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145. doi:10.1200/JCO.2006.09.2775
Author information
Authors and Affiliations
Corresponding author
Additional information
This is a commentary to doi:10.1007/s10549-008-0144-9.
Rights and permissions
About this article
Cite this article
Badve, S. Equivalency of RT-PCR and immunohistochemistry: fact or factoid. Breast Cancer Res Treat 116, 145–147 (2009). https://doi.org/10.1007/s10549-008-0176-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0176-1